GENERIC EQUIVALENT TO ATRIPLA 600/200/300 mg
As low as $178.88
In stock
SKU
Tenofovir_diso
Atripla is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil fumarate. It is indicated for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years and over with virologic suppression to HIV-1 RNA levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months.
| Prescription Required | Yes |
|---|---|
| Generic / Brand | GENERIC |
| Generic Name | Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate |
| Dispensing Country | India |
Write Your Own Review
